Cairo – Mubasher: The unaudited financial results of October Pharma reported an 18.75% year-on-year increase in its profits during the first nine months of 2019.
Net profits amounted to EGP 19 million during the January-September period, compared to EGP 16 million in the prior-year period, the company said in a statement to the Egyptian Exchange (EGX) on Monday.
Meanwhile, sales increased to EGP 376 million in the nine-month period ended 30 September from EGP 277 million in the corresponding period a year earlier.
It is worth mentioning that during the first half of 2019, October Pharma posted a net profit of EGP 3.33 million, compared to EGP 9.99 million in H1-18.
